Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 121 clinical trials
Impact of Exercise Intervention on the Phenome

intends to compare the influence of enhanced physical activity treatment with that of a standard education on liver steatosis, serum glucose and lipids level, insulin sensitivity, cardiovascular metabolic

  • 0 views
  • 20 Jun, 2021
  • 2 locations
Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies

that can be disturbed in case of vascular and/or biliary obstruction, chemotherapy-induced liver injuries or steatosis in overweight patients. Literature data (albeit originating from a single centre

scintigraphy
hepatectomy
  • 3 views
  • 26 Jan, 2021
  • 13 locations
Intermittent Fasting for NAFLD in Adults

NAFLD is a growing threat to public health. Currently, there is a significant need for highly effective treatments for NAFLD. Non-obese NAFLD (BMI<30kg/m2) is an increasingly recognized condition, sometimes described as "lean NAFLD". Intermittent Fasting (IF) may be uniquely beneficial in non-obese NAFLD. The purpose of this study is to …

  • 110 views
  • 19 Sep, 2021
  • 1 location
Bariatric Endoscopy and NAFLD

Find out how bariatric endocopy will influence clinical course of non alcoholic fatty liver disease.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Prevalence and Impact of NAFLD in Patients With Symptomatic Coronary Artery Disease (CORO-NASH)

of NAFLD among patients with symptomatic coronary artery disease. The secondary aims are: to analyze the impact of the presence and the severity spectrum of NAFLD (steatosis, steatohepatitis and

liver disease
steatosis
fibrosis
steatohepatitis
  • 1 views
  • 20 Sep, 2022
  • 1 location
Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death

beginning and after two hours of perfusion to determine steatosis and ATP content. During the perfusion, perfusate samples will be periodically tested for lactate, sodium, and potassium concentration, CO2

  • 0 views
  • 19 Apr, 2021
  • 1 location
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

. Sodium-glucose cotransporter type-2 (SGLT2) inhibitors are antidiabetic drugs that may prevent fibrosis/cirrhosis progression by reducing hepatic steatosis/inflammation, dampening renin

steatosis
hepatitis
ascites
fibroscan
cirrhosis
  • 0 views
  • 14 Jun, 2022
  • 1 location
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Nonalcoholic fatty liver disease (NAFLD) is common in individuals with obesity and is a significant threat to public health, because it can lead to impaired liver function and liver failure. Growth hormone is a hormone produced in the pituitary gland that helps regulate metabolism and growth. Individuals with obesity, on …

steatosis
fats
hepatic failure
magnetic resonance spectroscopy
hepatitis b surface antigen
  • 3 views
  • 18 Feb, 2022
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

after entry into the trial, a reduction in NAS composed of the non-weighted scores: (1) steatosis 0-3 (2) Inflammation 0-3 and (3) ballooning 0-2. Secondary goals include comparing the two treatment

steatosis
hemoglobin a1c
type 2 diabetes mellitus
obesity surgery
glucose intolerance
  • 260 views
  • 20 Sep, 2022
  • 1 location
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion

present in organs such as the liver, muscles and adipose tissue are involved in the establishment of metabolic deregulations linked to obesity (steatosis, insulin resistance, dyslipidemia). Thus

fats
cytokines
adipokine
glucagon-like peptide-1
diabetes
  • 0 views
  • 16 Oct, 2021
  • 1 location